Genworth Financial (GNW) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Celebrated 20th anniversary of IPO, highlighting transformation into a leading provider of life, annuity, and long-term care insurance, with a focus on aging care through CareScout and majority ownership of Enact mortgage insurance.
Achieved strong financial performance in 2024, including $718 million in adjusted operating income from Enact and $343 million in incremental LTC premium increases.
Returned $186 million to shareholders via share repurchases and reduced holding company debt to $790 million.
Expanded CareScout Quality Network to nearly 500 providers nationwide, with plans to add assisted living communities and direct-to-consumer offerings in 2025.
Recognized as a top workplace, with enhanced employee engagement and diversity initiatives.
Voting matters and shareholder proposals
Election of ten directors to serve until the 2026 annual meeting.
Advisory vote to approve named executive officer compensation (say-on-pay).
Approval of the 2025 Omnibus Incentive Plan.
Ratification of KPMG LLP as independent auditor for 2025.
Approval of amendment to remove "Pass-Through Voting" from Genworth Holdings' charter.
Board of directors and corporate governance
Board comprises ten members, 90% independent, with diverse backgrounds and an average tenure of 6.5 years.
Board refreshment: six new independent directors added since 2020, enhancing expertise in technology, risk, and governance.
Separate roles for CEO and Non-Executive Chair; annual board and committee self-evaluations.
Stockholder rights include annual director elections, majority voting, and ability to call special meetings at 25% ownership.
Robust code of ethics, anti-hedging/pledging, and stock ownership requirements for directors and executives.
Latest events from Genworth Financial
- Proxy details 2025 performance, capital returns, and key votes on directors, pay, and auditor.GNW
Proxy filing24 Mar 2026 - Enact drove Q4 profits and capital returns; CareScout expanded as LTC losses weighed on results.GNW
Q4 202524 Feb 2026 - Q2 2024 adjusted operating income rose to $125M, driven by Enact and strong capital returns.GNW
Q2 20242 Feb 2026 - Q3 net income rose to $85M, driven by Enact strength, LTC actions, and CareScout growth.GNW
Q3 202415 Jan 2026 - Q1 2025 net income was $54M, driven by Enact, CareScout growth, and capital returns.GNW
Q1 202523 Dec 2025 - Q4 net loss of $1M, strong Enact results, and $565M in share repurchases amid LTC headwinds.GNW
Q4 202421 Dec 2025 - Shareholders to vote on board, pay, incentive plan, auditor, and governance changes after a strong year.GNW
Proxy Filing1 Dec 2025 - Board recommends approval of all key proposals, including director elections and compensation.GNW
Proxy Filing1 Dec 2025 - Q2 2025 net income was $51M, with $94M in capital returns and CareScout network expansion.GNW
Q2 202516 Nov 2025